Text Size:
Color Theme:

Company Information

Key financial ratios and per-share data.

Ratios

REMUS PHARMACEUTICALS LTD.

NSE Code
REMUSSM
BSE Code
-
ISIN
INE0O5T01011
Industry
Pharmaceuticals
Financial Data

Ratio Analysis

Showing Standalone data

Table can be scrolled horizontally on smaller screens.

Five-year standalone Ratio Analysis for the selected company
ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
PER SHARE RATIOS
Basic EPS (Rs.)20.9633.75118.7283.2433.86
Diluted EPS (Rs.)20.9633.75118.7283.2433.86
Cash EPS (Rs.)23.3136.96120.2782.7735.41
Book Value[Excl.RevalReserv]/Share (Rs.)276.49411.24557.11176.3664.32
Book Value[Incl.RevalReserv]/Share (Rs.)276.49411.24557.11176.3664.32
Dividend / Share (Rs.)0.501.506.002.000.00
Revenue From Operations / Share (Rs.)79.79134.40431.07415.00247.17
PBDIT / Share (Rs.)31.0449.05161.15111.7447.91
PBIT / Share (Rs.)28.7045.87155.07107.3446.36
PBT / Share (Rs.)28.2145.23152.92105.2045.49
Net Profit / Share (Rs.)20.9833.79114.1978.3733.86
PROFITABILITY RATIOS
PBDIT Margin (%)38.8936.4937.3826.9219.38
PBIT Margin (%)35.9734.1335.9725.8618.75
PBT Margin (%)35.3533.6535.4725.3418.40
Net Profit Margin (%)26.2925.1326.4818.8813.69
Return on Networth / Equity (%)7.588.2120.4944.4352.64
Return on Capital Employeed (%)9.2810.0327.2743.9469.08
Return On Assets (%)6.467.0917.1524.5321.28
Long Term Debt / Equity (X)0.010.010.010.370.01
Total Debt / Equity (X)0.010.010.010.410.02
Asset Turnover Ratio (%)0.280.410.951.781.83
LIQUIDITY RATIOS
Current Ratio (X)4.724.873.581.390.83
Quick Ratio (X)4.564.673.461.350.66
Inventory Turnover Ratio (X)38.6041.8265.050.000.00
Dividend Payout Ratio (NP) (%)0.005.923.500.000.00
Dividend Payout Ratio (CP) (%)0.005.423.320.000.00
Earning Retention Ratio (%)0.0094.0896.500.000.00
Cash Earning Retention Ratio (%)0.0094.5896.680.000.00
COVERAGE RATIOS
Interest Coverage Ratio (%)63.0376.0374.8152.1454.94
Interest Coverage Ratio (Post Tax) (%)43.6053.3754.0137.5739.83
VALUATION RATIOS
Enterprise Value (Cr.)740.181316.51993.870.000.00
EV / Net Operating Revenue (X)7.8816.6315.650.000.00
EV / EBITDA (X)20.2545.5741.870.000.00
MarketCap / Net Operating Revenue (X)7.8716.6616.010.000.00
Retention Ratios (%)0.0094.0796.490.000.00
Price / BV (X)2.275.4412.380.000.00
Price / Net Operating Revenue (X)7.8716.6616.010.000.00
EarningsYield0.030.010.010.000.00

Source: Financial statements as reported by the company.